NCT05779215 Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
| NCT ID | NCT05779215 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xuanwu Hospital, Beijing |
| Condition | Acute Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2023-04-25 |
| Primary Completion | 2032-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2023-04-25 with a primary completion date of 2032-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is designed to observe the treatment options in real-world clinical practice as well as the safety and efficacy of different treatment strategies.
Eligibility Criteria
Inclusion Criteria: * The clinical diagnosis is acute ischemic stroke with large- or medium- vessel occlusion (the criteria followed the Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018) * Informed consent from the patient or surrogate Exclusion Criteria: * No additional exclusion criteria
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05779215 clinical trial?
This trial is open to participants of all sexes, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05779215 currently recruiting?
Yes, NCT05779215 is actively recruiting participants. Contact the research team at haojunwei@vip.163.com for enrollment information.
Where is the NCT05779215 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05779215 clinical trial?
NCT05779215 is sponsored by Xuanwu Hospital, Beijing. The trial plans to enroll 50,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.